Screener
Geron GERN CRO and clinical trial costs
CRO and clinical trial costs at other companies
Other financials
Where this comes from
Reported directly by Geron in its filing.
Tagged under the XBRL concept gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent.
The source filing: Geron’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:41 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886744-26-000037
| (In thousands) | JUNE 30,2026 | DECEMBER 31,2025 |
|---|---|---|
| Contract research organization and clinical trial costs | $5,190 | $3,677 |
| Manufacturing activities | 11,609 | 38,657 |
| Professional, legal and accounting fees | 3,623 | 881 |
| Interest payable | — | 3,110 |
| Accrued revenue adjustments | 6,704 | 3,486 |
| Other | 3,589 | 1,529 |
| $30,715 | $51,340 |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Geron's CRO and clinical trial costs?
- Geron (GERN) reported CRO and clinical trial costs of $5.19M in Q2 2026.
- How has Geron's CRO and clinical trial costs changed year-over-year?
- Geron's CRO and clinical trial costs decreased by 22.4% year-over-year, from $6.69M to $5.19M.
- What does CRO and clinical trial costs mean?
- CRO and clinical trial costs as reported by Geron Corp.
Ask your AI about Geron's cro and clinical trial costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude